close

Indraprastha Medical Corporation Ltd

Know More
NSEBSE

169.057.95 (4.93%)

03:40 PM,25th Sep 2023

169.108.05 (5.00%)

04:01 PM,25th Sep 2023

BSE : 532150

NSE : INDRAMEDCO

Sector : Health care

ISIN Code : INE681B01017

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Sep 25 2023 | 04:01 PM IST

Market Cap (₹ Cr)

1549

Turnover (₹ Cr)

0.40

Volume (Shares)

237091

Face Value

10

52-WK High

186.00

52-WK High Date

30 Aug 2023

52-WK Low

60.45

52-WK Low Date

03 Oct 2022

All Time High

186.00

All Time High Date

30 Aug 2023

All Time Low

5.00

All Time Low Date

15 Oct 1998

Indraprastha Medical Corporation Ltd

Indraprastha Medical Corporation was incorporated as Public Company on 16th March 1988. The main business of the company is to enhance the quality of life of patients by providing comprehensive high-quality hospital services on a cost-effective basis.The company came out with the public issue of 22918300 equity shares of Rs 10 each for cash at par aggregating Rs 229183000. IMCL is setting up a multi-disciplinary super speciality teritary care referral hospital at New Delhi. The hospital was originally planned to be located within the Indira Gandhi indoor stadium complex Mahatma Gandhi Marg New Delhi. In 1998-99 stroke unit to cater for strokes (Brain attack) with 4 beds has been established and a new OT complex consisting of 6 operation theatres has been commissioned. It has even set up a body mind medicine department based on ancient Eastern philosophy.During 1999-2000 the company signed a MOU with the Governments of Tanzania and Mauritius to treat patients from these countries sponsored by their Governments. It also has tie-ups with private air transport companies to transfer critical cases.A Puva UV therapy unit for treatment of complex skin conditions has been added in the dertamology department. The hospital has also installed an automated system in the microbiology unit for rapid cultures. A satellite clinic of the hospital providing out door consultations and diagnostic facilities was opened in Feb.'2001 in Delhi. This clinic also functions as a referral and sample collection centre for laboratory investigation.A high energy linear accelerator was installed with multileaf collimeter enabling selective radiation to the affected part sparing normal tissue. A four digit telephone number '1066' was introduced by the Hospital for Emergency Medical Services and this is the first of its kind in the country. Three more super specialites namely Joint replacementSpinal disorders and vascular surgeries have been started in the Hospital. The HIS is nearing completion and will be fully operational in the fag end of this financial year.During October 2001 the Hospital opened the Satellite Clinic at Golf LinkNew Delhi.The new 57-bed Apollo Hospital in Noida offering secondary and tertiary services became operational in 2006. A specialized Clinic for Chest Pain under the banner `Apollo Chest Pain Centre (ACPC)' was launched in three locations Bansal Hospital in Friends Colony Sehgal Nursing Home in Paschim Vihar and the Apollo Clinic in Vasant Kunj New Delhi.During 2009-10 Indraprastha Apollo Hospitals introduced Endoscopic Ultra Sonology (EUS) a major advancement in diagnosing and treating gastrointestinal and pancreato-biliary diseases. The Multi Organ Transplant unit of the Hospital performed 268 organ transplants in the financial year 2009-10 (117 liver and 151 kidney transplants). Significant renovation and upgradation work was completed during the year which should add to patient comfort and help achieve more operational efficiencies. Among others a new orthopaedics operation theatre a 5-bed ICU for critical cardiac care patients a 12 bed Multi Organ Transplant Unit for Renal Transplant patients a Mezzanine in the atrium for ICU patient attendants and international patient lounge were commissioned. 58 patient rooms and 3 OPDs were also renovated.A new Endoscopic Ultrasound Unit was commissioned in 2010-11. A Bone Marrow Transplant Unit one of the highest end of medical services was also created in the Hospital for intensive treatment and management of certain cancers like leukemia lymphomas and also some non-cancerous diseases like thalessaemia. A multi organ transplant unit was added to the increasing organ transplant demands. Renovated four OPD wings and day care facility. An OP pharmacy OPD billing counter Insurance TPA help desk and ICU patient lobby have been setup for the comfort and ease of patients.The expansion project undertaken by the Hospital was completed in 2011. In addition a Cosmetic Centre was set up to provide aesthetic medicine on an out-patient basis. Out of the additional beds 50 beds were commissioned. As part of the ongoing upgradation and renovation programme a number of departments and units such as Gynecology & Pediatric OPD Sample collection; Chemotherapeutics Admixture Room; Telemedicine Room; Fetal Medicine; Nucleic Acid Testing (NAT) Laboratory and Staff Cafeteria were refurbished to increase patient comfort and enhance operational efficiency. In order to meet the pressing demand of Dialysis and increased number of renal transplants seven additional beds were commissioned in the Dialysis unit taking the capacity to 28. A new Out Patient Wing (OPD 2C) - with 14 Consultation rooms was commissioned in place of 28 general ward beds to accommodate the new Consultants.The Expansion Project undertaken by the main Hospital to add 127 additional Beds comprising of 74 single rooms 33 general ward beds and 20 ICU beds was completed. With the completion of the expansion project the total bed strength of the Hospital has increased to 710 beds in 2012-13. The Apollo Institute of Robotic Surgery was launched in June 2012 and has been performing a good number of robotic surgeries with the Da-Vinci Robotic Surgical System. The Hospital commissioned the Cosmetic Clinic in 2012.In 2013-14 the Apollo Obesity and Metabolic Surgery (Bariatric surgery) Centre was commissioned. The Apollo Institute of Robotic Surgery which was instituted last year performed 173 surgeries during the year. The Renal Transplant services were commenced in September 2013 and resulting to this a total of 18 transplants were conducted in the Noida hospital during the year. The Pain Clinic was started in January 2014 offering integrated and comprehensive Pain Management for all kinds of pain. Given the rising burden of Non-Communicable Diseases and Diabetes the Sugar Clinic was also started to help patients in better management of Diabetes and prevention of associated complications. The hospital also expanded its Emergency department with 10 additional beds being added along with a complete renovation. The total strength of the unit stands at 20 beds. Also the Urology Nephrology and Dermatology OP areas underwent renovation. A large number of equipments were replaced or upgraded in various specialities including Oncology Fetal Medicine Cosmetics Cardiology and Microbiology along with OT and other equipment at the main hospital and in Noida.Project Priceless an Apollo wide initiative supported by inputs from Bain & Company to improve overall patient experience and improve patient and physician advocacy for the Hospital commenced in June 2014. Plastic and Cosmetic Surgery: New Anti-aging procedures have been introduced such as Mid-face volumization; Skin lifting and tightening Ulthera procedure for face upper neck lower neck and arms; and Cool Sculpting for non-invasive localized fat reduction for body contouring. In addition a multitude of new investigation services have been started including Chromosomal Genetic Study Contrast Enhanced Ultrasonography etc. Various new Diagnostic or Surgical processes have also been added in different specialties such as Clot Evacuation in Urology Tracheal or Bronchial Stent placement in Respiratory medicine FET PET MRI for better imaging of brain tumours Molecular Imaging Nuclear Medicine etc.The Central Asia e-Network link was launched on 12th July 2015. The event featured a tele-consultation for a cardiac patient between doctors in Osh city in Southern Kyrgyzstan in Bishkek and with Apollo Hospital and AIIMS. The Hospital completed a successful cadaver split liver transplant wherein both the parts of the liver were given to two adult recipients. This was the first split liver transplant in two adults reported in the city and the second in India.Indraprastha Apollo Hospitals started providing Geriatric Services starting December 2016. New technique of Molecular Micro Film Array (Biofire) for rapid detection of micro-organisms in cases of meningitis/ encephalitis sepsis respiratory infections and gastroenteritis were introduced in Molecular Microbiology. In 2018-19 the Hospital commissioned a new state-of-the-art Chemotherapy Unit with 30 beds.During 2021-22 the Bone Marrow Transplant (BMT) project Unit created a dedicated wing for BMT unit with 8 single rooms 3 general ward beds and 1 procedure room which was commissioned in August 2021. Bronchoscopy and PFT lab were cohorted in one area to make it man-power optimal. A 25-bedded Dialysis Unit was created in the Lower Basement of the hospital to create a better patient experience. Orthopaedic operating theatre was moved from Ground Floor to the first floor so that all theatres are cohorted in one area. The Radiology Unit was renovated to improve patient experience.

Indraprastha Medical Corporation Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

1549

EPS - TTM (₹) [S]

10.51

P/E Ratio (X) [S]

4.08

Face Value (₹) 10
Latest Dividend (%)30.00
Latest Dividend Date 15 Sep 2023
Dividend Yield (%) 1.77
Book Value Share (₹) [S]41.39
P/B Ratio (₹) [S]4.08
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)
Motilal Oswal S&P BSE Healthcare ETF 0.01 393 0.09

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

161.10

169.15

Week Low/High

156.50

169.15

Month Low/High

152.00

186.00

Year Low/High

60.45

186.00

All time Low/High

4.00

186.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week5.23%5.92%-2.33-2.28%
1 Month0.71%1.08%1.752.12%
3 Month83.75%83.65%4.835.41%
6 Month115.46%116.31%14.7716.11%
1 Year157.50%157.31%13.6413.55%
3 Year222.92%222.61%76.5978.05%

Financials

Graph
Table

Bulk/ Block

ALL
NSE
BSE
ALL
BUY
SELL
DateClient NameExchangeTransactionQuantityPrice
09-06-2021GRAVITON RESEARCH CAPITAL LLPNSESELL70786899.69
09-06-2021GRAVITON RESEARCH CAPITAL LLPNSEBUY70786899.69
19-05-2021GRAVITON RESEARCH CAPITAL LLPNSEBUY60855090.88
19-05-2021GRAVITON RESEARCH CAPITAL LLPNSESELL60855090.97
06-05-2021GRAVITON RESEARCH CAPITAL LLPNSESELL135805691.09
06-05-2021GRAVITON RESEARCH CAPITAL LLPNSEBUY135805691.02
06-05-2021NK SECURITIES RESEARCH PRIVATE LIMITEDNSESELL65770390.83
06-05-2021NK SECURITIES RESEARCH PRIVATE LIMITEDNSEBUY65770390.76
06-05-2021QE SECURITIESNSESELL63830391.25
06-05-2021QE SECURITIESNSEBUY63826591.21

Load More

Peer Group Comparison

NamePrice(In Rs)Chg(%)Mkt Cap(Rs Cr)Sales(Rs Cr)Profit(Rs Cr)EPS(Rs)P/E(x)

Shareholding Pattern

Jun 2023
Archive
CategoryShare(%)
Promoter51.00
Financial Institutions Banks0.00
Foreign Institutional Investors0.37
Insurance Companies0.00
Mutual Funds Uti0.00
Other Institutional Investors0.01
Indian Public29.31
Others Non Institutional Investors19.31
Custodians0.00

Corporate Action

Announcement DatePurposeFromToRemarks
Data Not Found

Price History

Search for Price History

DateOpenHighLowCloseSharesTrades
Data Not Found

Load more

Company Info

Company Information

Chairman & Non Executive Dir. : Jasmine Shah

Vice Chairman & Non executive : Prathap C Reddy

Non Executive Director : Suneeta Reddy

Non Executive Director : Sangita Reddy

Non Executive Director : Vineeta Rai

Independent Non Exe. Director : S Regunathan

Independent Non Exe. Director : Satnam Arora

Independent Non Exe. Director : Deepak Vaidya

Independent Non Exe. Director : Arun Rai

Independent Non Exe. Director : Vinayak Chatterjee

Independent Non Exe. Director : MADHUMITA GANGULI

Independent Non Exe. Director : Menaka Gurusswamy

Independent Non Exe. Director : Salil Singhal

Non Executive Director : Vikram Bhat

Non Executive Director : Mahesh Verma

Executive Director & MD : P Shivakumar

Registered Office: Sarita Vihar, Delhi-Mathura Road,New Delhi,New Delhi-110076 Ph: 91-11-26925858/26925801

Email:imclshares@apollohospitals.com

URL:http://www.apollohospdelhi.com